Articles

Podcasts

Videos

Brett King, MD, PhD, reviews how the drug class has altered the state of chronic skin disease management in this year alone.

2022: The Year of JAK Inhibitors

Why patience is key following the major FDA decision earlier this year.

Brett King, MD, PhD: Following Up the Ruxolitinib Cream Approval for Vitiligo

An interview on the SDPA 2022 presentation of Dr. Woolery-Lloyd in which she discusses dermatoses affecting patients of color.

Heather Woolery-Lloyd, MD, FAAD: Interview on Common Skin of Color Dermatoses

A discussion with Dr. Markowitz on her presentation from SDPA 2022, during which she described various gaps in knowledge on skin health and future innovations she hoped to see.

Orit Markowitz, MD: Artificial Intelligence, Patient Knowledge on Skin Cancer

New long-term phase 3 data show adults and adolescents both improved measures of quality of life when treated with either of 2 doses of ruxolitinib cream.

Ruxolitinib Cream Improves Atopic Dermatitis Pain, Anxiety and Depression Over 52 Weeks

An interview with Dr. Markowitz on her presentation at SDPA 2022 presentation entitled ‘Skin of Color,’ regarding differentiating skin cancer from other conditions.

Orit Markowitz, MD: How to Distinguish Skin Cancer from Less Dangerous Skin Conditions

Findings from the ongoing LIBERTY AD OLE trial show the sustained long-term effect of the biologic therapy for eczema.

Dupilumab Maintains Atopic Dermatitis Clearance, Symptom Benefit Over 4 Years

A discussion with Dr. Orozco on her SDPA 2022 presentation, discussing useful resources for physicians and PAs looking to get involved in the PAs Go Beyond campaign.

Jennifer Orozco, DMSc, PA-C: Resources for Physician Associates and ‘PAs Go Beyond’

Online survey results show adults with psoriasis in specific areas may be treating and monitoring disease without clinician guidance—sometimes out of embarassment.

Patients with Intertriginous Area Psoriasis Frequently Report Embarrassment, Sexual Distress

Long-term, real-world data show the IL-23 inhibitor benefits patient-reported  measures of psychological wellbeing.

Tildrakizumab Improves Wellbeing, Quality of Life for Psoriasis Patients

Vitiligo

Vitiligo condition center page is a comprehensive resource for clinical news and insights on the dermatologic condition. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the affected skin of vitiligo patients.

Acne

The HCPLive acne page is a resource for medical news and expert insights on dermatological disease. This page features expert-led coverage, articles, videos, and research on the therapies and development of treatments for chronic acne, and more.

Atopic Dermatitis

Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Chronic Idiopathic Urticaria

The HCPLive chronic idiopathic urticaria page is a comprehensive resource for clinical news and insights on CIU. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for urticaria, and more.

Plaque Psoriasis

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.

Rosacea

On the HCPLive rosacea page, resources on the topics of medical news and expert insight into acne rosacea can be found. Content includes articles, interviews, videos, podcasts, and breaking news on the skin condition, and more.

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Dermatology

Latest News